Found 4 matching trials
Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines PHASE3 This protocol posting deals with objectives \& outcome measures of an exten...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in Russia PHASE4 The purpose of this study is to assess reactogenicity and safety of simulta...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course PHASE4 The study will compare the immunogenicity and the reactogenicity of INFANRI...
Show More Location
GSK Investigational Site
Learn More & Join Trial
3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age PHASE2 This study evaluated the safety and immunogenicity of 3 formulations of Hib...
Show More Location
GSK Investigational Site
Learn More & Join Trial